Wednesday, 1 July 2026

The EU deeptech sector faces national fragmentation and research-to-treatment bottlenecks, while policy discussions centre on institutional reform and energy integration.
Listen — today's brief

Welcome to EU Pulse. Today, we delve into the EU's deep tech sector, grappling with national fragmentation and bottlenecks in translating research into treatment. A recent PWC report reveals significant regional fragmentation in Belgium's biotech sector. This hinders global scaling, with calls for a national consortium to unify efforts and boost competitiveness. That's a clear barrier to innovation, and this mirrors concerns in the Netherlands, where the industry warns of a critical lag. Indeed. Holland Bio highlights that the Netherlands is falling behind in clinical trials. This impedes drug accessibility and the vital translation of research into effective treatments for citizens. These challenges in deep tech innovation underscore the need for broader EU policy discussions, particularly around institutional reform. Precisely. Ireland's current EU presidency is prompting a reexamination of the unanimity rule and the use of veto power. Discussions are intensifying due to anticipated EU enlargement. The ability of individual member states to block collective decisions is certainly a key point of contention. Moving to another critical area, energy integration and climate monitoring are also high on the agenda. They are. Global average sea surface temperatures reached an unprecedented 20.98 degrees Celsius in June. This new record, reported by the Copernicus Marine Service, surpasses previous highs from 2023 and 2024. A stark reminder of the deepening global climate crisis. It's clear the EU faces a complex policy landscape across multiple fronts. From consolidating biotech efforts to streamlining institutional decision-making and addressing climate change, the pressure for effective unified action is mounting. For more detailed insights on these stories and other European developments, visit today's edition of EU Pulse at eu.eu. Goodbye for now.
- Belgian Biotech
Belgian biotech fragmentation hinders global scale
A recent PwC report reveals regional fragmentation is impeding the growth of Belgium's biotech sector. The report advocates for a national consortium to unify efforts, aiming to boost global competitiveness in life sciences innovation.
Read article →
- Dutch Health Research
Netherlands' clinical trial lag impedes drug access, industry warns
Hollandbio warns that the Netherlands is falling behind in clinical trials, hindering both drug accessibility and the translation of research into effective treatments. This raises questions about Europe's capacity to convert life sciences innovation into tangible healthcare benefits.
Read article →
- Ireland's EU Presidency
Ireland takes EU Council helm, prioritising CAP and fisheries reforms
Ireland has assumed the Council presidency, setting the stage for critical legislative debates on the Common Agricultural Policy and EU Fisheries Policy. The nation's strong interest in farming and fisheries will heavily influence discussions, particularly concerning the Multiannual Financial Framework.
Read article →
- EU Institutional Reform
Ireland's Presidency Sparks Debate on EU Veto Power Reform
Ireland's EU presidency is prompting a re-examination of the unanimity rule and the use of veto power. Discussions are intensifying due to anticipated EU enlargement and specific national political stances, such as Hungary's.
Read article →
- Climate Monitoring
Ocean Temperatures Set New Record
Global average sea surface temperatures in June reached 20.98C, setting a new record. This surpasses previous highs from 2023 and 2024, highlighting a deepening global climate crisis.
Read article →
- EU Policy Beat
EU grapples with climate records, biotech hurdles, and migration policy shifts
The European Union faces a complex policy landscape, marked by record ocean temperatures, challenges in biotech innovation, and an intensified EPP stance on migration.
Read article →